Global, regional, and National burden of falls among midlife women from 1990 to 2021 and projections to 2050: A systematic analysis for the global burden of disease study 2021
Between 1990 and 2021, the global burden of falls among perimenopausal women has exhibited a persistent upward trend, and projections indicate that this burden will likely remain at a high level in the future. This alarming situation underscores the urgent need for targeted interventions. Identifying key risk factors for falls in perimenopausal women is essential for guiding the allocation of public health resources and formulating precise intervention strategies. It is imperative to implement nationwide, cost-effective measures, such as osteoporosis and fall risk screening, the promotion of exercise programs that enhance muscle strength and balance, and, where appropriate, consideration of pharmacological interventions (such as estrogen) to reduce fall risk. This intervention will significantly reduce the risk of falls and associated burdens among perimenopausal women.
Authors
- Cheng Zhao (ORCID: https://orcid.org/0000-0002-4244-9354)
- Hao Liang (ORCID: https://orcid.org/0000-0001-7534-5124)
- Yushuai Mi
- Shijun Zhao (ORCID: https://orcid.org/0000-0001-5554-0336)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-1397-5224)
- Lang Wang (ORCID: https://orcid.org/0000-0003-2608-1593)
- Tian Gao (ORCID: https://orcid.org/0000-0003-2142-9124)
- Ziping Liu (ORCID: https://orcid.org/0000-0002-6167-3634)
- Yinlu Ding (ORCID: https://orcid.org/0000-0002-6496-5069)
- Junjian Liu (ORCID: https://orcid.org/0000-0002-7093-0508)
- Xianglin Zhu (ORCID: https://orcid.org/0000-0002-2667-5298)
Institutions
- Second Hospital of Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Aging Clinical and Experimental Research
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1007/s40520-025-03210-5
- Citations
- 2
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- National Health Commission of the People's Republic of China